Federal Register / Vol. 74, No. 177 / Tuesday, September 15, 2009 / Notices 47257 

response for a total screener burden of 

4,000 (respondents) + 6,000 (ineligibles 

screened) x .0167 hours = 167 hours. 

The survey will require an average of 20 

minutes (0.33 hours) per respondent 

and we expect that the variation in 

burden across respondents will be 

small. This estimate is based on average 

interview time for the 2006 Food Safety 

Survey. The proposed number of 

respondents is 4,000, each of whom will 

be asked to complete a one-time 

telephone interview that requires no 

preparation time. Additionally, 200 

initial nonrespondents will be asked to 

participate in a short version of the 

survey to conduct a nonresponse 

analysis. This is expected to take 6 

minutes (0.10 hours). Therefore, the 

total estimated public reporting burden 

is 1,541 hours. 

We have revised the burden table. In 

the 60-day notice published on 

September 17, 2008, we estimated the 

total burden to be 1,421 hours. The total 

burden of 1,541 hours estimated in table 

1 of this document includes an 

additional 120 hours, which resulted 

from correcting a typographical error in 

line 4 of the table. The hours per 

response in line 4 of table 1 changed 

from 0.3 to 0.33. 

Dated: September 1, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–22121 Filed 9–14–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0406] 

Agency Emergency Processing Under 

the Office of Management and Budget 

Review; Tobacco Product 

Establishment Registration and 

Submission of Certain Health 

Information; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of September 1, 2009 (74 FR 

45219). The document announced the 

proposed collection of information 

concerning the submission of tobacco 

product establishment registration and 

submission of certain health 

information, including ingredient listing 

and health related documents, as 

required by the Family Smoking 

Prevention and Tobacco Control Act. 

The document was published with an 

incorrect date for submitting written or 

electronic comments on the proposed 

collection. This document corrects that 

error. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794, 

Jonnalynn.Capezzuto@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

E9–21099, appearing on page 45219, in 

the Federal Register of Tuesday, 

September 1, 2009, the following 

correction is made: 

On page 45219, in the second column, 

in the ‘‘DATES’’ section, beginning in the 

second line, ‘‘September 16, 2009’’ is 

corrected to read ‘‘October 1, 2009’’. 

Dated: September 8, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–22120 Filed 9–14–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group: 

Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

National Center for Injury Prevention 

and Control Initial Review Group, 

Department of Health and Human 

Services, has been renewed for a 2-year 

period through August 20, 2011. 

For information, contact Dr. Richard 

Waxweiler, Executive Secretary, 

National Center for Injury Prevention 

and Control Initial Review Group, 

Department of Health and Human 

Services, 1600 Clifton Road, M/S F63, 

Atlanta, Georgia 30341, telephone 770/ 

488–4850, or fax 770/488–4422. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and othercommittee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 4, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–22140 Filed 9–14–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Purified Saxitoxin for Food Safety 

Applications 

Description of Technology: Available 

for licensing as a biological material for 

research purposes is purified saxitoxin. 

Saxitoxin is the parent compound in a 

family of natural toxins that can occur 

in seafood and can cause food borne 

illness. Highly purified saxitoxin is vital 

for the development, validation, and 

calibration of detection methods for 

these toxins, as well as for fundamental 

studies in physiology and pain 

management. Interested parties may 

license the compound for conjugation 

chemistry and radiolabeling with the 

end goal of generating a research 

reagent. 


sroberts on DSKD5P82C1PROD with NOTICES